Literature DB >> 17988824

[Daily interruption of sedation in intensive care unit patients with renal impairment: remifentanil-midazolam compared to fentanyl-midazolam].

M Belhadj Amor1, R Ouezini, K Lamine, M Barakette, I Labbène, M Ferjani.   

Abstract

OBJECTIVE: We compared extubation time following daily interruption of sedation in intensive care unit patients with renal impairment with two sedation regimes remifentanil-midazolam and fentanyl-midazolam. STUDY
DESIGN: Prospective, randomized double-blind trial. PATIENTS AND METHODS: Patients with renal impairment needing mechanical ventilation for more than 48 hours. Two groups: remifentanil (R) and fentanyl (F), Infusion rates were titrated to achieve the desired Ramsay score. The two groups received midazolam (2.5 mg then 0.1 mg/kg/h).
RESULTS: Nineteen patients were included. Patient's characteristics, mean sedation time and sedation quality were comparable. Extubation time was significantly shorter in R group (1480+/-980 versus 2880+/-1280 min, P=0.04). Weaning time was also shorter in R group (220+/-164 versus 720+/-480 min). Agitation on weaning was comparable in the two groups. Group R received significantly more morphine than group F after interruption of sedation.
CONCLUSION: Daily interruption of sedation with remifentanil is associated with shorter weaning and extubation time in patients with renal impairment. However further studies are necessary to determine if this issue is associated with lower rate of ventilation induced complications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17988824     DOI: 10.1016/j.annfar.2007.10.005

Source DB:  PubMed          Journal:  Ann Fr Anesth Reanim        ISSN: 0750-7658


  6 in total

Review 1.  Daily sedation interruption versus no daily sedation interruption for critically ill adult patients requiring invasive mechanical ventilation.

Authors:  Lisa Burry; Louise Rose; Iain J McCullagh; Dean A Fergusson; Niall D Ferguson; Sangeeta Mehta
Journal:  Cochrane Database Syst Rev       Date:  2014-07-09

2.  A prospective, randomized, double-blind, multicenter study comparing remifentanil with fentanyl in mechanically ventilated patients.

Authors:  Claudia Spies; Martin Macguill; Anja Heymann; Christina Ganea; Daniel Krahne; Angelika Assman; Heinrich-Rudolf Kosiek; Kathrin Scholtz; Klaus-Dieter Wernecke; Jörg Martin
Journal:  Intensive Care Med       Date:  2010-12-17       Impact factor: 17.440

3.  Comparison between remifentanil and other opioids in adult critically ill patients: A systematic review and meta-analysis.

Authors:  Shuguang Yang; Huiying Zhao; Huixia Wang; Hua Zhang; Youzhong An
Journal:  Medicine (Baltimore)       Date:  2021-09-24       Impact factor: 1.817

4.  Remifentanil-propofol analgo-sedation shortens duration of ventilation and length of ICU stay compared to a conventional regimen: a centre randomised, cross-over, open-label study in the Netherlands.

Authors:  F Willem Rozendaal; Peter E Spronk; Ferdinand F Snellen; Adri Schoen; Arthur R H van Zanten; Norbert A Foudraine; Paul G H Mulder; Jan Bakker
Journal:  Intensive Care Med       Date:  2008-10-24       Impact factor: 17.440

5.  Sedation and analgesia in intensive care: a comparison of fentanyl and remifentanil.

Authors:  F Cevik; M Celik; P M Clark; C Macit
Journal:  Pain Res Treat       Date:  2011-07-02

Review 6.  Could remifentanil reduce duration of mechanical ventilation in comparison with other opioids for mechanically ventilated patients? A systematic review and meta-analysis.

Authors:  Yibing Zhu; Yinhua Wang; Bin Du; Xiuming Xi
Journal:  Crit Care       Date:  2017-08-03       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.